|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chronic Pain | |||||
| 2 | Interventions listed in this trial | ||||
| OROS Hydromorphone | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Hydromorphone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Opioid | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Narcotics | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Neuromed Pharmaceuticals | |||||